Sintilimab plus Bevacizumab biosimilar IBI305 and chemotherapy as a first-line treatment in advanced gastric or gastroesophageal junction adenocarcinoma (SBAGA): a single-arm, phase Ib/II study
- Mo Cheng
- Pengfei Zhang
- Qiancheng Hu
- Jitao Zhou
- Ruihong Dai
- Wenke Li
- Jing Wei
- Menghui Xu
- Yanna Lei
- Xiaoying Li
- Xiufeng Zheng
- Qian Huang
- Zhiping Li
- Bo Zhang
- Wen Zhuang
- Zhixin Chen
- Xiaolong Chen
- Chaoyong Shen
- Weihan Zhang
- Kai Liu
- Linyong Zhao
- Xiaonan Yin
- Boqiang Peng
- Zhaolun Cai
- Yuan Yin
- Ji Chen
- Chunjuan Liu
- Deying Kang
- Mojin Wang
- Hongfeng Gou
- Kun Yang
- Jiankun Hu
- Feng Bi
- Ming Liu
2026-08-15